GlassScriptPhysician profile
Gino J Sedillo
NPI 1982680179
$87,047.35
in general payments reported to CMS, 2019-2025
36 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $14K · 2021: $17K · 2022: $5,370 · 2023: $17K · 2024: $6,417 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $14K · Travel and Lodging: $429 · Education: $11.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,165.00 |
| Food and Beverage | $14,169.19 |
| Travel and Lodging | $428.68 |
| Education | $11.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $46,731.31 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Abbott Laboratories | $18,454.91 | 2019-2025 | Mitraclip, Triclip, Portico |
| Boston Scientific Corporation | $4,015.90 | 2019-2025 | Eluvia, Enroute Transcarotid Neuroprotection System, General - Stents |
| Medtronic Vascular, INC. | $2,465.94 | 2019-2020 | |
| Medtronic, INC. | $2,217.45 | 2021-2025 | Hawkone, Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,740.75 | 2019-2025 | Evoque, Pascal, Konect Resilia |
| Bard Peripheral Vascular, INC. | $1,725.00 | 2024 | |
| Biotronik INC. | $1,336.86 | 2020-2025 | Biomonitor, Acticor 7 Vr-T Dx, Edora 8 Dr-T |
| Penumbra, INC. | $883.43 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Inari Medical, INC. | $872.88 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $688.42 | 2019-2024 | Impella |
| Reflow Medical INC | $686.89 | 2024-2025 | |
| Stryker Corporation | $525.72 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Silk Road Medical, INC. | $517.54 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Angiodynamics, INC. | $502.78 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $484.50 | 2019-2025 | Intracardiac Undivided, (Az7) Lasers |
| Cardiovascular Systems INC. | $431.52 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Biosense Webster, INC. | $395.11 | 2021-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Shockwave Medical, INC | $382.78 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $339.46 | 2019-2022 | |
| Veryan Medical Incorporated | $319.92 | 2020-2021 | |
| Cvrx, INC. | $223.59 | 2021-2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $214.80 | 2020-2024 | Farxiga |
| Siemens Medical Solutions USA, INC. | $170.09 | 2021-2022 | |
| Contego Medical, INC | $126.68 | 2024 | |
| Intact Vascular, INC. | $110.39 | 2019 | |
| Cardiva Medical, INC. | $106.11 | 2024-2025 | Savvywire, Other |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.55 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $87.68 | 2021-2022 | |
| Amgen INC. | $62.29 | 2023-2025 | Repatha, Repatha |
| Cardinal Health 200 LLC | $42.16 | 2019 | |
| Pfizer INC. | $23.79 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.75 | 2023 | Jardiance |
| Terumo Medical Corporation | $18.18 | 2023 | Angio-Seal |
| Asahi Intecc USA, INC. | $17.22 | 2025 | Asahi Peripheral Vascular Wires |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$48,619.99 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$134,954.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gino Sedillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.